DA Davidson resumed coverage of Phreesia with a rating of Buy and set a new price target of $33.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/9/2025 | $26.00 | Overweight | Barclays |
| 11/13/2025 | $32.00 | Outperform | BMO Capital Markets |
| 9/5/2025 | $33.00 | Buy | DA Davidson |
| 8/27/2025 | $36.00 | Outperform | Mizuho |
| 1/8/2025 | $24.00 → $32.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 2/26/2024 | $35.00 | Buy | Truist |
| 1/17/2024 | $30.00 → $32.00 | Neutral → Buy | DA Davidson |
| 1/3/2024 | $29.00 | Overweight | Barclays |
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2025. "I am very proud of our team's strong execution in the fiscal third quarter, which is reflected throughout this letter from our revenue and profit results to product updates and client stories," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q3 Fiscal 2026 Stakeholder Letter. Fiscal Third Quarter Ended October 31, 2025 Highlights1 Total revenue was $120.3 million in the quarter, up 13% year-over-year. Average number of healthcare services clients ("AHSCs") was
Phreesia today announced that Megan Turco, Director of Client Experience for Phreesia Network Solutions, has been named to MM+M's 2025 40 Under 40 list. MM+M's annual 40 Under 40 list celebrates standout talent across healthcare marketing and communications. This year's honorees were chosen for their impact in shaping the future of medical marketing through creativity, leadership and a commitment to a more inclusive, patient-centered industry. "Megan has this rare ability to make operational excellence feel energizing," said Danielle Lynch, Vice President of Client Experience at Phreesia. "She brings empathy, creativity and a whole lot of fun to the work—and that combination has been trul
Phreesia, a leader in patient intake, outreach and activation, has been named to the 2025 Deloitte Technology Fast 500™. Now in its 31st year, the prestigious list ranks the 500 fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies in North America. "We're proud to be named to the Deloitte Fast 500 for the first time," said Phreesia CEO Chaim Indig. "This achievement is a testament to our team's hard work, creativity and commitment to our mission of making care easier every day. Phreesia's growth reflects our dedication to delivering value to healthcare organizations and their patients, and it's exciting to see that recognized." "This ye
8-K - Phreesia, Inc. (0001412408) (Filer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
Barclays initiated coverage of Phreesia with a rating of Overweight and set a new price target of $26.00
BMO Capital Markets initiated coverage of Phreesia with a rating of Outperform and set a new price target of $32.00
DA Davidson resumed coverage of Phreesia with a rating of Buy and set a new price target of $33.00
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2025. "I am very proud of our team's strong execution in the fiscal third quarter, which is reflected throughout this letter from our revenue and profit results to product updates and client stories," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q3 Fiscal 2026 Stakeholder Letter. Fiscal Third Quarter Ended October 31, 2025 Highlights1 Total revenue was $120.3 million in the quarter, up 13% year-over-year. Average number of healthcare services clients ("AHSCs") was
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal third quarter 2026 financial results after the close of market trading on Monday, Dec. 8, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or visit t
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025. "I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net income positive quarter, we have expanded our reach and capabilities, positioning us well for the future. I am also excited to share that we entered into a definitive agreement to acquire AccessOne, a market leader in providing financing solutions for healthcare receivables. Please refer to the AccessOne press release published earlier today for addition
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
Phreesia will work with the NAI to shape the national conversation around data privacy and promote consumer choice and transparency As part of the company's ongoing commitment to consumer data privacy, Phreesia is pleased to announce it has joined the Network Advertising Initiative (NAI), a non–profit organization and the leading self-regulatory association dedicated to responsible data collection and use for digital advertising. As a member, Phreesia will work with the NAI to promote consumer-centric privacy practices in healthcare and take a leadership role in shaping the national conversation around data privacy. "We are excited to join the NAI, an organization that shares our dedicati
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Audrey Gato, Vice President of Client Solutions, has been named to The Software Report's list of the Top 50 Women Leaders in SaaS of 2023. Honorees were chosen based on their leadership and contributions to the Software-as-a-Service industry. This is the sixth consecutive year a female leader from Phreesia has been named to the list. Previous Phreesia awardees include Allison Hoffman, General Counsel; Kristin Roberts, Vice President of Product Management; Kharen Hauck, Vice President of Marketing; Amy VanDuyn, Senior Vice President of Human Resources; and Sara DiNardo, Vice President of Client Solutio